The randomized PICSO-AMI-I trial: pressure-controlled intermittent coronary sinus occlusion in AMI Mostrare di più
Aaysha Cader interviews Giovanni Luigi De Maria about the results of the PICSO-AMI-I Trial which he presented during the TCT Congress 2023 in San Francisco.
Results of this first multicenter, prospective randomized trial of pressure controlled intermittent coronary sinus occlusion (PiCSO) therapy used in conjunction with primary percutaneous coronary intervention (pPCI) indicated that it did not reduce myocardial infarct size in patients with anterior ST-segment elevation myocardial infarction (STEMI).
Read more news from #TCT2023 here:
https://www.pcronline.com/News/Whats-new-on-PCRonline/2023/TCT/PCRonline-at-TCT-2023
Medis presents: a series of 11 interviews with QFR® KOL’s | Prof. Giovanni Luigi De Maria Mostrare di più
Medis presents: a series of 11 interviews with QFR® KOL’s | Prof. Giovanni Luigi De Maria
During the EuroPCR 2022 in Paris, we have had the opportunity to engage in many interesting conversations with various QFR® users. This is the eighth out of 11 interviews. Prof. Giovanni Luigi De Maria is an Interventional Cardiology Consultant at the Oxford University Hospitals NHS Foundation Trust. Thank you for participating in this interesting talk!
An introduction to Dr Giovanni Luigi De Maria Mostrare di più
In this introductory video, esteemed consultant interventional cardiologist, Dr Giovanni Luigi De Maria, tells us why he decided to become a doctor, and what the most rewarding aspect of his daily profession is.
If you wish to consult with Dr De Maria today, simplt visit his Top Doctors profile here: https://www.topdoctors.co.uk/doctor/giovanni-luigi-de-maria
✔ Follow us on Instagram: https://bit.ly/3fSrqXb
✔ Follow us on Facebook: https://bit.ly/3t5kGsW
✔ Follow us on Twitter: https://bit.ly/39TidKh